Sanjay Mathew
Vice Chair for Research at Baylor College of Medicine
Key Impact
Leading expert in experimental therapeutics for treatment-resistant mood and anxiety disorders.
Background & Research
Dr. Sanjay Mathew directs the Mood and Anxiety Disorders Program at Baylor College of Medicine. His research program is dedicated to discovering novel pharmacotherapies for difficult-to-treat depression and PTSD, with a primary focus on the rapid-acting effects of ketamine. He has significantly contributed to the literature on the pathophysiology of anxiety and the clinical management of treatment-resistant patients.
Collaboration Network
34 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Depressive DisordersTreatment-Resistant Depression (TRD)Major Depressive Disorder (MDD)Anxiety DisordersSuicidalityPublic Health, Prevention & Behaviour ChangeNeuroimaging & Brain MeasuresSubstance Use Disorders (SUD)Safety & Risk ManagementHealthy VolunteersAdolescentsBipolar DisorderPTSDSchizophreniaImmunology & InflammationVeteransOlder AdultsNeurocognitive Disorders